IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer
IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer
Read moreFri, 30th Oct 2009 06:11
IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer
Read more(Sharecast News) - Clinical-stage drug development company Evgen announced on Monday that Helen Kuhlman had been appointed to the post of chief business officer, taking up the role from 1 April.
Read moreIN BRIEF: Evgen says no patient safety concerns in STAR Covid-19 trial
Read more(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Thursday that after a review of the first 60 patients enrolled, the data safety monitoring committee for the 'STAR' Covid-19 trial had concluded that there were no concerns over patient safety or data quality that would prevent its continuation.
Read moreTRADING UPDATES: Cambria drives on amid virus; Argo crypto mining up
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read more(Sharecast News) - Clinical stage drug development company Evgen Pharma said on Wednesday that a total of 102 patients had been recruited and randomised to the 'STAR', or 'SFX-01 Treatment for Acute Respiratory infections', trial.
Read moreIN BRIEF: Evgen Pharma Recruits Over 100 For Respiratory Drug Trial
Read moreIN BRIEF: Intuitive Investments Buys Shares in Evgen For GBP175,000
Read moreIN BRIEF: Evgen Pharma's GBP11 Fundraise To Support Lead Candidate
Read moreEvgen Shares Rise On Further Positive Test Results For SFX-01
Read moreIN BRIEF: Evgen Pharma Notes Positive Preclinical Data For SFX-01
Read moreIN BRIEF: Evgen Pharma Recruits Patients For STAR-Covid-19 Trial
Read moreUK EARNINGS SUMMARY: Character Group Lowers Dividend As Profit Drops
Read more(Sharecast News) - Clinical-stage drug development company Evgen Pharma reported financial performance in line with its expectations in its first half on Thursday, with revenue coming in at £0.19m, compared to nil a year earlier.
Read more